1. Home
  2. VRDN vs HCSG Comparison

VRDN vs HCSG Comparison

Compare VRDN & HCSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRDN
  • HCSG
  • Stock Information
  • Founded
  • VRDN 2006
  • HCSG 1976
  • Country
  • VRDN United States
  • HCSG United States
  • Employees
  • VRDN N/A
  • HCSG N/A
  • Industry
  • VRDN Medical Specialities
  • HCSG Assisted Living Services
  • Sector
  • VRDN Health Care
  • HCSG Health Care
  • Exchange
  • VRDN Nasdaq
  • HCSG Nasdaq
  • Market Cap
  • VRDN 1.6B
  • HCSG 1.3B
  • IPO Year
  • VRDN N/A
  • HCSG N/A
  • Fundamental
  • Price
  • VRDN $23.63
  • HCSG $17.87
  • Analyst Decision
  • VRDN Strong Buy
  • HCSG Strong Buy
  • Analyst Count
  • VRDN 10
  • HCSG 4
  • Target Price
  • VRDN $36.78
  • HCSG $19.25
  • AVG Volume (30 Days)
  • VRDN 1.5M
  • HCSG 743.3K
  • Earning Date
  • VRDN 11-13-2025
  • HCSG 10-22-2025
  • Dividend Yield
  • VRDN N/A
  • HCSG N/A
  • EPS Growth
  • VRDN N/A
  • HCSG N/A
  • EPS
  • VRDN N/A
  • HCSG 0.54
  • Revenue
  • VRDN $305,000.00
  • HCSG $1,808,303,000.00
  • Revenue This Year
  • VRDN N/A
  • HCSG $8.88
  • Revenue Next Year
  • VRDN $34,044.63
  • HCSG $5.09
  • P/E Ratio
  • VRDN N/A
  • HCSG $33.08
  • Revenue Growth
  • VRDN 5.90
  • HCSG 6.26
  • 52 Week Low
  • VRDN $9.90
  • HCSG $9.13
  • 52 Week High
  • VRDN $27.20
  • HCSG $20.00
  • Technical
  • Relative Strength Index (RSI)
  • VRDN 62.01
  • HCSG 57.15
  • Support Level
  • VRDN $21.65
  • HCSG $18.33
  • Resistance Level
  • VRDN $24.23
  • HCSG $19.43
  • Average True Range (ATR)
  • VRDN 1.11
  • HCSG 0.70
  • MACD
  • VRDN -0.03
  • HCSG 0.11
  • Stochastic Oscillator
  • VRDN 68.07
  • HCSG 52.72

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).

About HCSG Healthcare Services Group Inc.

Healthcare Services Group Inc is a provider of housekeeping and facility management services to the healthcare industry. The company operates two business segments, both contributing roughly equally to the company's revenue: Housekeeping, laundry, linen, and other services; and Dietary department services. Housekeeping includes management of clients' housekeeping departments, cleaning, disinfecting and sanitizing, laundry, bed linen, and uniform services. Dietary consists of food purchasing, meal preparation, and providing dietitian consulting services. Its clients are nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States of America.

Share on Social Networks: